Myocardial Protective Effect of Gas Signal Molecule Hydrogen Sulfide on Cardiovascular Disease

Authors

  • Lijuan Li Medical College of Three Gorges University
  • Fei Zou Medical College of Three Gorges University

DOI:

https://doi.org/10.30564/jams.v3i3.2131

Abstract

Cardiovascular diseases increase continually in the worldwide scale, and its specific pathogenesis has not been completely clear. The gas signal molecule hydrogen sulfide (H2S) is a new type of neuroactive substance, which plays many biological roles in many systems such as cardiovascular system. In recent years, a lot of research has confirmed H2S has myocardial protective effect on cardiovascular diseases such as atherosclerosis, ischemia-reperfusion injury, hypertension and heart failure. This paper reviews the research status of myocardial protective effect of H2S on cardiovascular diseases.

Keywords:

Hydrogen sulfide, Cardiovascular disease, Atherosclerosis, Ischemia reperfusion injury, High blood pressure, Heart failure

References

[1] Ma liyuan, wu ya-zhi, Chen wei-wei. Introduction of key points in Chinese cardiovascular disease report 2018 [J]. Chin J hypertension,2019 (08):712-716.

[2] Chen Yihan. Opportunities and challenges in research on prevention and treatment of cardiovascular diseases in China [J]. World Science, 2020(04):34-36.

[3] Xu S, Liu Z, Liu P. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis. Int J Cardiol. 2014 (2):313-317.

[4] Changyong Li, Min Hu, Yuan Wang, Huan Lu, Jing Deng, Xiaohong Yan.Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stress[J].International Journal of Clinical and Experimental Pathology, 2015 (7):7740-7751.

[5] Paul BD, Snyder SH. Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol. 2018(149):101-109.

[6] Chen J,Alberts I,Li X.Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders [J].Int J Dev Neurosci,2014(01):35-41.

[7] Damba, Turtushikh Zhang, Mengfan Buist-Homan, et al. Hydrogen sulfide stimulates activation of hepatic stellate cells through increased cellular bio-energetics. Nitric Oxide, 2019: 26-33.

[8] Li N, Wang MJ, Jin S, et al. The H2S Donor NaHS Changes the Expression Pattern of H2S-Producing Enzymes after Myocardial Infarction. Oxid Med Cell Longev. 2016.

[9] Zhang S H, Li J, Ma L, et al. Hydrogen sulfide metabolism and neuroprotective effect. Chin J Multiorgan Disease for the Elderly, 2019 (04): 73-77.

[10] Gao L, Xu Z, Yin Z, Chen K, Wang C, Zhang H. Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease. Inflamm Res. 2015 (8):627-635.

[11] Yang r, kong h, et al. Changes of hydrogen sulfide in patients with coronary heart disease [J]. Chinese journal of gerontology,2019(16):3875-3877.

[12] Salloum FN. Hydrogen sulfide and cardioprotection--Mechanistic insights and clinical translatability. Pharmacol Ther. 2015(152):11-17.

[13] He bo-sheng, cao qia-lin, lei yong-ge. Relationship between hydrogen sulfide and acute myocardial infarction efficacy and reperfusion injury [J]. Chinese medical innovation,2019 (14):49-52.

[14] Sodha NR, Clements RT, Feng J, et al. Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2009 (4):977-984.

[15] Li L, Whiteman M, Guan YY, et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation. 2008 (18):2351-2360.

[16] Li Hui-xian, Li Fang-jiang, SHI Jin-zheng. Changes of Bcl-2 and Bax expression after simvastatin pretreatment of rat myocardial IRI. Shanxi Pharmaceutical Journal, 2017 (21): 26-28.

[17] Minamishima S, Bougaki M, Sips PY, et al. Hydrogen sulfide improves survival after cardiac arrest and cardio pulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation, 2009 (10): 888-896

[18] Citi V,Piragine E,Testai L,et al.The role of Hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury[J].CurrMedChem, 2018 (34):4380-4401.

[19] Miller TW, Wang EA, Gould S, et al. Hydrogen sulfide is an endogenous potentiator of T cell activation[J]. J Biol Chem, 2012 (6): 4211-4221

[20] Al-Magableh MR, Kemp-Harper BK, Ng HH, et al. Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro[J]. Naunyn Schmiedebergs Arch Pharmacol, 2014 (1): 67-74.

[21] Zhang p, zhang h, Yang c t, et al. Novel hydrogen sulfide donor 8 L antagonized H9c2 myocardial cells by upregulation of nf-e2-related factor 2 [J]. Chinese journal of arteriosclusion,2015 (6): 561-566.

[22] Abd Elmoneim H,Sharabi F,Mohy El Din M,et al.Potassium channels modulate the action but not the the synthesis of hydrogen sulfide in rat corpuscavernosum[J].LifeSci,2017(189):39-43.

[23] Hong Xie,Qingrong Xu,Jia Jia,Guizhen Ao,Ying Sun,Lifang Hu,Nabil J. Alkayed,Chen Wang,Jian Cheng. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux[J]. Biochemical and Biophysical Research Communications,2015 (3).

[24] Wang Y,Zhao X,Jin H,et al． Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice．Arterioscler Thromb Vasc Biol,2009(29):173- 179.

[25] Zhao ZZ,Wang Z,Li GH,et al. Hydrogen sulfide inhibits macrophage-derived foam cell formation[J].Exp Biol Med (Maywood),2011 (2) : 169-176．

[26] Du J, Huang Y, Yan H, et al. Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway. J Biol Chem. 2014 (14):9741-9753.

[27] Xiao Lin. Mechanism of Hydrogen sulfide improving arterial endothelial dysfunction in hypertension [D]. Hebei Medical University, 2016.

[28] Polhemus DJ,Li Z,Pattillo CB,et al. A novel hydrogen sulfide prodrug,SG1002,promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients.Cardiovasc Ther,2015(33):216-226

[29] Song zhiqiang, zhang jianpeng. Effects of hydrogen sulfide on vascular smooth muscle cells [J]. Biotechnology communications,2015 (06) :871-875

[30] Wang jie-wen, zhang ya-ping. Progress in myocardial fibrosis in patients with "H" type hypertension. Journal of integrated traditional Chinese and western medicine,2015(3): 187-188

[31] Peng Chao, Lu Yan. Central cardiovascular effects of a new gas signaling molecule hydrogen sulfide. Chinese Journal of Hypertension,2016(24):628-631

[32] Liu YH, Lu M, Xie ZZ, et al. Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats. Antioxid Redox Signal, 2014(20): 759-769.

[33] Kovačić D, Glavnik N, Marinšek M, et al. Total plasma sulfide in congestive heart failure. J Card Fail. 2012 (7):541-548.

[34] Givvimani S, Munjal C, Gargoum R, et al. Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol (1985). 2011 (4):1093-1100.

[35] Wu T,Li H,Wu B,et al.Hydrogen Sulfide Reduces Recruitment of CD11b+Gr-1+ Cells in Mice With Myocardial Infarction. Cell Transplant. 2017(5):753-764.

[36] J Beltows KJ. Hydrogen sulfide in pharmacology and medicine—an update. Pharmacol Rep, 2015 (3): 647-658.

Downloads

Issue

Vol. 3 , Iss. 3 (July 2020)

Article Type

Articles

License

Copyright and Licensing

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

Journal of Advances in Medicine Science publishes accepted manuscripts under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Authors who submit their papers for publication by Journal of Advances in Medicine Science agree to have the CC BY-NC 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for non-commercial use. As long as you follow the license terms and original source is properly cited, anyone may copy, redistribute the material in any medium or format, remix, transform, and build upon the material.

License Policy for Reuse of Third-Party Materials

If a manuscript submitted to the journal contains the materials which are held in copyright by a third-party, authors are responsible for obtaining permissions from the copyright holder to reuse or republish any previously published figures, illustrations, charts, tables, photographs, and text excerpts, etc. When submitting a manuscript, official written proof of permission must be provided and clearly stated in the cover letter.
The editorial office of the journal has the right to reject/retract articles that reuse third-party materials without permission.

Journal Policies on Data Sharing

We encourage authors to share articles published in our journal to other data platforms, but only if it is noted that it has been published in this journal.